Calumet Specialty Products
CLMT
61 hedge funds and large institutions have $230M invested in Calumet Specialty Products in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 20 reducing their positions, and 15 closing their positions.
33% more call options, than puts
Call options by funds: $12M | Put options by funds: $9.06M
8% more capital invested
Capital invested by funds: $213M → $230M (+$16.6M)
1.06% more ownership
Funds ownership: 20.4% → 21.46% (+1.1%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
13% less funds holding
Funds holding: 70 → 61 (-9)
35% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 20
53% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$13.1M |
| 2 |
Brown Advisory
Baltimore,
Maryland
|
+$11M |
| 3 |
DMKJ
David M. Knott Jr
|
+$6.48M |
| 4 |
BCM
Bienville Capital Management
New York
|
+$3.72M |
| 5 |
PI
PEAK6 Investments
Chicago,
Illinois
|
+$630K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$3.67M |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$2.76M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.24M |
| 4 |
SM
SG3 Management
Dorado,
Puerto Rico
|
-$2.24M |
| 5 |
WWM
Windsor Wealth Management
Indianapolis,
Indiana
|
-$2.15M |
CLMT Hedge Fund Activity: Q1 2022 in Review
61 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Calumet Specialty Products (CLMT) for Q1 2022, worth a combined $230M — up 7.8% from $213M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of CLMT and 7 opened new positions — a net loss of 8 holders — while 20 trimmed existing stakes and 13 added.
The largest buyer was Fidelity Investments, adding an estimated $13.1M. The largest seller was Morgan Stanley, cutting an estimated $3.67M.
- 61 institutional investors held Calumet Specialty Products (CLMT) as of Q1 2022, down from 70 in Q4 2021.
- Funds reported $230M of Calumet Specialty Products stock for Q1 2022, up 7.8% quarter-over-quarter.
- 7 funds opened new Calumet Specialty Products positions in Q1 2022 and 15 closed out, a net change of -8 holders.
- The largest Calumet Specialty Products buyer in Q1 2022 was Fidelity Investments, an estimated $13.1M added.
- The largest Calumet Specialty Products seller in Q1 2022 was Morgan Stanley, an estimated $3.67M sold.
Based on aggregated 13F filings for Q1 2022.